121 related articles for article (PubMed ID: 19331413)
1. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.
Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V
J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413
[TBL] [Abstract][Full Text] [Related]
2. Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.
Brizzi A; Cascio MG; Frosini M; Ligresti A; Aiello F; Biotti I; Brizzi V; Pertwee RG; Corelli F; Di Marzo V
J Med Chem; 2011 Dec; 54(24):8278-88. PubMed ID: 22044209
[TBL] [Abstract][Full Text] [Related]
3. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
[TBL] [Abstract][Full Text] [Related]
5. Novel, potent THC/anandamide (hybrid) analogs.
Bourne C; Roy S; Wiley JL; Martin BR; Thomas BF; Mahadevan A; Razdan RK
Bioorg Med Chem; 2007 Dec; 15(24):7850-64. PubMed ID: 17827022
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
7. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.
Duarte CD; Tributino JL; Lacerda DI; Martins MV; Alexandre-Moreira MS; Dutra F; Bechara EJ; De-Paula FS; Goulart MO; Ferreira J; Calixto JB; Nunes MP; Bertho AL; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2007 Mar; 15(6):2421-33. PubMed ID: 17275312
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
[TBL] [Abstract][Full Text] [Related]
10. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
11. Development of novel tail-modified anandamide analogs.
Yao F; Li C; Vadivel SK; Bowman AL; Makriyannis A
Bioorg Med Chem Lett; 2008 Nov; 18(22):5912-5. PubMed ID: 18723350
[TBL] [Abstract][Full Text] [Related]
12. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
13. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.
Di Marzo M; Casapullo A; Bifulco G; Cimino P; Ligresti A; Di Marzo V; Riccio R; Gomez-Paloma L
J Pept Sci; 2006 Sep; 12(9):575-91. PubMed ID: 16534762
[TBL] [Abstract][Full Text] [Related]
15. Anandamide effects on 5-HT(3) receptors in vivo.
Rácz I; Bilkei-Gorzo A; Markert A; Stamer F; Göthert M; Zimmer A
Eur J Pharmacol; 2008 Oct; 596(1-3):98-101. PubMed ID: 18775693
[TBL] [Abstract][Full Text] [Related]
16. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Haller VL; Cichewicz DL; Welch SP
Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
[TBL] [Abstract][Full Text] [Related]
17. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level.
Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G
Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592
[TBL] [Abstract][Full Text] [Related]
18. 7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.
Rempel V; Volz N; Hinz S; Karcz T; Meliciani I; Nieger M; Wenzel W; Bräse S; Müller CE
J Med Chem; 2012 Sep; 55(18):7967-77. PubMed ID: 22916707
[TBL] [Abstract][Full Text] [Related]
19. First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands.
Appendino G; Cascio MG; Bacchiega S; Moriello AS; Minassi A; Thomas A; Ross R; Pertwee R; De Petrocellis L; Di Marzo V
FEBS Lett; 2006 Jan; 580(2):568-74. PubMed ID: 16406364
[TBL] [Abstract][Full Text] [Related]
20. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
Wise LE; Shelton CC; Cravatt BF; Martin BR; Lichtman AH
Eur J Pharmacol; 2007 Feb; 557(1):44-8. PubMed ID: 17217945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
